Industry Veteran Brings Extensive Experience Driving the Commercialization of Robotic Technologies Within Healthcare
BIONIK Laboratories Corp., a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, announced the appointment of Loren Wass as Chief Commercial Officer, effective September 3, 2019. Wass will report to Dr. Eric Dusseux, BIONIK’s Chief Executive Officer.
Wass joins BIONIK from ReWalk Robotic, where as Vice President of Sales and Reimbursement he was responsible for the commercialization of several rehabilitation robotic exoskeletons, including the first robotic exoskeleton cleared by the FDA for paralyzed individuals to use to ambulate at home and in the community and the first soft exo-suit cleared by the FDA for stroke gait therapy in a clinical setting. In the first full year after FDA clearance, Wass grew sales by 60% year-over-year. He also led all efforts in reimbursement leading to a national coverage policy by the U.S. Veterans Association and numerous positive coverage decisions by private health insurers. Mr. Wass served on ReWalk’s Executive Committee that was responsible for the overall management and strategic direction of the company.
Prior to ReWalk, Mr. Wass held several key sales leadership roles. He served as Vice President of Sales for DJO (DonJoy Orthopedics), where he led a team of more than 250 direct and distributor-based sales representatives and exceeded new product launch goals by 15%. Additionally, he held a leadership role in several merger activities while there. Before joining DJO, Mr. Wass served as National Sales Director at Ottobock, and held the position of Vice President of Sales and Field Operations for Myomo, Inc. He brings more than 25 years of experience in the orthopedic and neurological rehabilitation market to his role at BIONIK.
“We are excited to welcome Loren to BIONIK and look forward to his immediate impact on our global sales initiatives and market expansion for our industry-leading InMotion robotic therapy systems,” said Dr. Dusseux. “Loren has deep experience within the robotic rehabilitation market and has had tremendous success driving the commercialization and adoption of robotic technologies within clinical settings. His leadership will be important to us as we continue expansion throughout the U.S. while increasing penetration of foreign markets. We welcome him to BIONIK.”
“I am thrilled to be joining the talented team at BIONIK, and to add my expertise within the robotic rehabilitation industry to help continue the tremendous growth and success the company has achieved this past year,” said Wass. “With industry-leading robotic rehabilitation devices in clinical settings across the U.S., and innovative products in development to serve the home health care market, I believe BIONIK is well positioned to further establish itself as a market leader.”